MNG Laboratories

MNG Laboratories is an internationally recognized clinical diagnostic leader specializing in neurogenetic and complex biochemical testing. Our portfolio includes movement disorders, epilepsy, muscular dystrophies, intellectual disabilities, metabolic and other inherited disorders. Our extensive offering of next-generation sequencing panels, proprietary Genome MaNaGer™ database and our Neurogenetic Answers™ reporting platform is recognized by genetic experts around the world. We are proud to offer first-in-class reporting and fast turnaround times. With over 15 years of neurogenetic experience, and powered by a culture of discovery and advancement, MNG Laboratories delivers results that make a difference for patients and their families. MNG Laboratories offers CLIA and CAP certified reports and adheres to current ACMG guidelines and recommendations.

Website

https://www.mnglabs.com

External link for MNG Laboratories

Industry

Biotechnology

Company size

11-50 employees

Headquarters

Atlanta, Georgia

Type

Privately Held

Founded

2001

Specialties

Next-Generation Sequencing, Neurogenetic Testing, Epilepsy, Movement Disorders, Neuromuscular, Neurobehavioral, Neurometabolic, Cardiovascular, Cellular Energetics, Whole Exome Sequencing, Intellectual Disabilities, Neuroendocrine, Mitochondrial Disease, and Neurochemistry